|
|
||||||||
J Thorac Cardiovasc Surg 1995;109:212-217
© 1995 Mosby, Inc.
CARDIAC AND PULMONARY REPLACEMENT |
Denver, Colo.
Supported by National Institutes of Health grant R29HL49398.
Address for reprints: David A. Fullerton, MD, Cardiothoracic Surgery, C-310, University of Colorado Health Sciences Center, 4200 East Ninth Ave., Denver, CO 80262
Abstract
Pulmonary vascular resistance is significantly increased in the transplanted lung. If cardiopulmonary bypass is required, the transplanted lung is reperfused with activated blood elements, which might exacerbate the reperfusion injury. The purpose of this study was to examine the influence of cardiopulmonary bypass on the following mechanisms of pulmonary vasomotor control in a dog model of autologous lung transplantation: (1) endothelium-dependent cyclic guanosine monophosphatemediated relaxation (response to acetylcholine), (2) endothelium-independent cyclic guanosine monophosphatemediated relaxation (response to nitroprusside), (3)ßadrenergic cyclic adenosine monophosphatemediated relaxation (response to isoproterenol). Autologous right lung transplants were performed with (n = 4 dogs) and without (n = 5 dogs) bypass. Lungs were stored in cold saline solution (4° C, 3 hours) before reimplantation. Pulmonary vasomotor control mechanisms were studied in isolated pulmonary atrial rings immediately after harvest and 1 hour after implantation. Ten rings were studied in each group at time. Statistical analysis was by analysis of variance. Without bypass, endothelium-dependent cyclic guanosine monophosphatemediated relaxation andßadrenergic cycle adenosine monophosphatemediated relaxation were significantly impaired, although endothelium-independent cyclic guanosine monophosphatemediated relaxation was not. Use of bypass produced significantly greater impairment of both endothelium-dependent cyclic guanosine monophosphatemediated relaxation andß-adrenergic cyclic adenosine monophosphatemediated relaxation. In addition, use of bypass produced significant dysfunction of endothelium-independent cyclic guanosine monophosphatemediated relaxation as well. We concluded that using cardiopulmonary bypass to perform lung transplantation greatly exaggerates pulmonary vasomotor dysfunction in the transplanted lung. This dysfunction may contribute to significantly higher pulmonary vascular resistance in the transplanted lung if cardiopulmonary bypass is used. (J THORACCARDIOVASCSURG1995;109-212-7)
This article has been cited by other articles:
![]() |
M. Saitoh, M. Tsuchida, T. Koike, K. Satoh, M. Haga, T. Aoki, S.-i. Toyabe, and J.-i. Hayashi Ultrafiltration attenuates cardiopulmonary bypass-induced acute lung injury in a canine model of single-lung transplantation J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1447 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Lau, D. M. Hoganson, B. F. Meyers, R. J. Damiano Jr, and G. A. Patterson Use of an Apical Heart Suction Device for Exposure in Lung Transplantation Ann. Thorac. Surg., April 1, 2006; 81(4): 1524 - 1525. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. Szeto, D. Kreisel, G. C. Karakousis, A. Pochettino, D. H. Sterman, R. M. Kotloff, S. M. Arcasoy, D. A. Zisman, N. P. Blumenthal, R. J. Gallop, et al. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 241 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujita, H. Date, K. Ueda, I. Nagahiro, M. Aoe, A. Andou, and N. Shimizu Experimental study on size matching in a canine living-donor lobar lung transplant model J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 104 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Khatchatourian, C. Chevalley, A. Spiliopoulos, and M. Licker Myocardial revascularization and bilateral lung transplantation without cardiopulmonary bypass Eur. J. Cardiothorac. Surg., November 1, 2001; 20(5): 1042 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshida, N. A. Flavahan, M. Horibe, N. G. Smedira, and P. A. Murray Endothelial defect mediates attenuated vasorelaxant response to isoproterenol after lung transplantation Am J Physiol Heart Circ Physiol, January 1, 1999; 276(1): H159 - H166. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Sheridan, T. N. Hodges, M. R. Zamora, D. L. Lynch, J. M. Brown, D. N. Campbell, and F. L. Grover Acute and chronic effects of bilateral lung transplantation without cardiopulmonary bypass on the first transplanted lung Ann. Thorac. Surg., November 1, 1998; 66(5): 1755 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Myles Aspects of Anesthesia for Lung Transplantation Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1998; 2(2): 140 - 154. [Abstract] [PDF] |
||||
![]() |
D. A. Fullerton and R. C. McIntyre Jr Inhaled Nitric Oxide: Therapeutic Applications in Cardiothoracic Surgery Ann. Thorac. Surg., June 1, 1996; 61(6): 1856 - 1864. [Abstract] [Full Text] |
||||
![]() |
H. Date, A. N. Triantafillou, E. P. Trulock, M. S. Pohl, J. D. Cooper, and G.A. Patterson INHALED NITRIC OXIDE REDUCES HUMAN LUNG ALLOGRAFT DYSFUNCTION J. Thorac. Cardiovasc. Surg., May 1, 1996; 111(5): 913 - 919. [Abstract] [Full Text] |
||||
![]() |
D. A. Fullerton, M. B. Mitchell, D. N. Jones, A. Maki, and R. C. McIntyre Jr. PULMONARY VASOMOTOR DYSFUNCTION IS PRODUCED WITH CHRONICALLY HIGH PULMONARY BLOOD FLOW J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 190 - 197. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |